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ABSTRACT
Background and the Purpose of the study: Central Angiotensin Converting Enzyme (ACE) has 
an important role on cerebral microcirculation and metabolism. However, its role in terms of 
protecting the brain from ischemic/reperfusion (I/R) injury are debatable. This study evaluated 
the role of ACE, using enalapril as ACE inhibitor, in protection of the brain from I/R injury 
during transient focal cerebral ischemia (TFCI) in normotensive rat. 
Method: Male Sprague Dawley rats (280-320g) randomly assigned to control ischemic and 
enalapril pre-treated ischemic groups. Enalapril was injected intraperitoneally 1 h before middle 
cerebral artery occlusion (MCAO) at the dose of 0.03 or 0.1 mg/kg. Cerebral ischemia was 
induced by 60 min MCAO followed by 24 hrs reperfusion. After evaluation of neurological 
deficit scores (NDS) the animal was sacrificed for assessment of cerebral infarction and 
edema. 
Results: TFCI induced cerebral infarctions (283±18 mm3), brain edema (4.1±0.4%) and swelling 
(9.8±1.5%) with NDS of 3.11±0.36. Non-hypotensive dose of enalapril (0.03 mg/kg) improved NDS 
(1.37±0.26), reduced cerebral infarction (45%), brain edema (54%) and swelling of  the 
lesioned hemispheres (34%) significantly. However, hypotensive dose of enalapril (0.1 mg/kg) could 
improve neurological activity (1.67±0.31) and failed to reduce cerebral infarction (276±39mm3) 
and swelling (10.4±1.4%). 
Conclusion: In the rat model of transient focal cerebral ischemia, inhibition of angiotensin 
converting enzyme with non-hypotensive doses of enalapril has the benefit of improving 
neurological activity, reducing cerebral infarction, brain swelling and edema of acute ischemic 
stroke. Therefore, it is reasonable to conclude that central renin-angiotensin system may 
participate in ischemic/reperfusion injury of the cerebral cortex. 
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INTRODUCTION
The critical role of renin–angiotensin system (RAS) 
in cardiovascular and fluid hemostasis is well 
established and some evidences exist about the role 
of angiotensin-converting enzyme (ACE) activity 
and angiotensin II in ischemic neuronal injury (1). 
It is suggested that inhibition of the RAS might be 
effective not only in reducing the incidence of stroke 
but also attenuating neuronal injury after stroke (2). 
Recent clinical studies revealed that ACE inhibitors, 
which are used as anti-hypertensive drugs, reduce 
the risk and the severity of secondary attacks of the 
stroke (3). Long term treatment with ACE inhibitors 
has shown to prevent the occurrence of stroke in 
spontaneously hypertensive or salt loaded-Dahl salt-
sensitive rats (4, 5). Moreover, ACE inhibitors are 
reported to improve neurological recovery from 
cerebral ischemia/reperfusion (I/R) injury and reduce 
the mortality rate in spontaneously hypertensive 
rats (6). Pathological remodeling of cerebral vessels 
that occur during chronic hypertension is reported 
to interfere with the outcome of ACE inhibition and 
other neuroprotective agents (5). Therefore, this 
study was designed to induce cerebral I/R injury 
in normotensive rats to alleviate the interaction of 
hypertension in protective action of ACE inhibitors. 
Experimental-induced transient focal cerebral ischemia 
is widely used to examine the functional impairments 
resemble to those that have been observed in human 
stroke (7). Previously the beneficial effects of non-
hypotensive dose of enalapril, an ACE inhibitor, 
in improving neurological activity and reducing 
cerebral infarction volume in normotensive rats 
exposed to 60 min middle cerebral artery occlusion 
(MCAO) was reported (8). Brain edema is a 
destructive phenomenon that worsens cerebral I/R 
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